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CHAPTER I 
INTRODUCTION 
A. Introductory Remarks and Statement of the Problem 
The relationship of group specific substances of 
human body fluids to various abnormalities became a 
specialized form of research about three decades ago with 
the finding by Landsteiner and Weiner (1940) that iso-sensi-
tization of the blood of an expectant mother to a blood 
factor of fetal blood cells resulted in erythroblastosis 
fetalis. 
This dramatic explanation of the etiology of 
erythroblastosis renewed interest in the possibilities that 
other diseases and pathological phenom~na are genetically 
inter-related to various blood factors or other group 
specific substances of body fluids. 
While a review shows extensive investigations into 
blood groups and disease relationships have been accomplished, 
it is noted that little work has been done concerning the 
presence of group specific substances of saliva and the 
occurrence of congenital abnormalities. 
Over seventy-five percent of human beings have ABH 
blood group substances corresponding to those of their red 
cells present in their saliva. The presence or absence of 
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these water soluble antigens A, B, or H in saliva divide 
humanity into two groups: secretors and non-secretors. 
2 
One of the most severe congenital conditions that 
Orthodontics has to deal with is cleft lip/palate. The 
purpose of this research is to investigate the possible 
existence of a relationship between ABH secretor status and 
cleft lip/palate condition. 
B. Review of the Literature 
The study of heredity has progressed in a little 
more than a century from Mendel's symbolic representation of 
inheritance in pea plants (1865) to an interpretation at the 
molecular level, related to the chemical processes involved 
in growth and maturation. The mechanism of heredity is now 
seen as a remarkable unifying feature of all kinds of living 
things. Significant advances serving to explain this mech-
anism have included Morgan (1933) and his discoveries on 
hereditary functions of the chromosomes, Lederberg and 
Beadle (1941) with their investigations of genetic mechanisms 
and discovery of how genes transmit hereditary characteristics 
and the elucidation of the three-dimensional molecular struc-
ture of DNA by Crick, Watson, and Wilkins (1962). 
These principles of inheritance have been shown to 
fully apply to the blood groups discovered by Landsteiner 
(1900). 
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The work of Yamakami (1926) on the presence of A 
and B antigens in secretions and the investigations of Lehrs 
(1930) and Putkonen (1930) on saliva established that the 
presence of blood group substances were not limited to the 
red cells. 
In 1932 Sasaki found that group specific substance 
of all blood types may either be present in large amounts 
in saliva or entirely lacking. Schiff and Sasaki (1932) 
found that the ability to secrete the group substances of 
types o, A and B is inheritable and is dependent on the 
Mendelian factors S and s. Friedenreich and Hartmann also 
confirmed that the secretion of these substances was a 
genetically determined trait that obeyed the Mendelian law 
of inheritance (1938). 
Schiff (1940) stated that the saliva of a so-called 
11 secretor 11 contained one of the blood group specific sub-
stances A or B, in accord with the blood group characteristic 
of the individual. In a 11 non-secretor 11 the group specific 
substance corresponding to the blood group in the red cells 
was absent from the saliva. The occurrence of secretors 
and non-secretors was studied in two groups of whites and a 
group of Negroes. Statistically, the difference between the 
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two white groups was negligible, whereas that between the 
Negroes and each of the white groups was definitely 
significant. 
Weiner and Belkin {1943) tested a series of thirty 
pairs of saliva samples from mothers and their new-born 
infants for their content of group specific substances. The 
distinction between secretors and non-secretors was as sharp 
in the infants as in the mothers, indicating that this 
characteristic is fully developed at birth. 
The heredity of the ABO system and the secreter/ 
non-secreter system must be considered as established accord-
ing to Andresen (1961). The ABO and secretor/non-secretor 
systems are now considered an entity in which all antigens 
are chemically related, but in which independent systems of 
genes determine the phenotypes. 
Present evidence of blood groups and the relationship 
to disease concludes that persons belonging to different 
blood groups differ in their susceptibility to certain 
diseases of adult life. 
Important and significant information about racial 
differences has been accumulated from studies based on the 
blood group systems by Mourant (1954). 
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Weiner (1947) suggested that investigating the 
possible relationship between !so-sensitization and congenital 
malformations would be fruitful. This suggestion was supported 
by reports in the literature of high incidence of congenital 
malformations among erythroblastotic infants. 
Most of the work with blood groups and group specific 
substances has dealt with anomalies or disease of the gastro-
intestinal tract. The classical work that has encouraged 
many recent investigations in this field is the work of Aird 
in 1953. He reported a correlation between cancer of the 
stomach and a disturbance in the frequency of types in the 
ABO blood groups. The data showed the frequency of blood 
Group O to be less in patients with cancer of the stomach 
than in the general population. 
Other diseases such as essential hypertension, 
ulcerative colitis, diabetes mellitus and rheumatic fever 
have been studied by various workers and compared to ABO 
blood group frequencies. A frequency of Group O was found 
in males with diabetes mellitus. Hypertension and rheumatic 
fever essentially showed no difference to the normal 
population. 
6 
The relationship between blood groups and osteogensis 
imperfecta was studied in Swedish families by Smars (1961) 
and no significant association or linkage relation was found. 
Buckwalter (1956) studied a varied group of con-
genital anomalies and tested the group for blood types. The 
malformations included those of nervous systems, cardio-
vascular, respiratory, genitourinary, and gastrointestinal 
system. Inspection of the combined data for all the 
anomalies, indicated no statistical significant differences 
existed between the anomalies and the individual blood types. 
The study of specific groups of anomalies also failed to show 
evidence of statistically significant differences. 
The increasing frequency of the appearance of cleft 
palate and lip among newborn inf ants in Poland and the lack 
of concise explanation as to the etiology, prompted Handzel 
and Nowakowski (1961) to make a study of the possible 
relationship between the blood groups, Rh factor and·the 
incidence of these defects. Blood groups of children 
demonstrating these defects and blood groups of their mothers 
were determined. Rh factor for both mother and child and 
frequently blood of both parents was typed. The conclusion 
drawn from Hanazel's study was that no relationship was 
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shown between development of cleft palate and blood groups 
or Rhesus factor of the child. 
Investigation by Roberts (1957) demonstrated that 
the genetically determined character of salivary ABH non-
secretion is associated with duodenal ulcer. Clarke, Evans, 
McConnell, and Sheppard (1959) showed that non-secretors of 
Group O are particularly likely to develop peptic ulcers. 
In a study by Dodge (1967) secretor status appeared 
to be unrelated to the occurrence of pyloric stenosis. 
Considerable literature has developed attempting to 
associate blood groups and secretions of the body tissues 
with increased susceptibility.to various diseases. The 
report by Aird in 1953 linking cancer of the stomach with 
blood group A has been corroborated, reviewed, then refuted, 
and even denied by different authors. Other associations 
such as group O with duodenal ulcer, group A with pernicious 
anemia and group A with diabetes mellitus, and non-secretors 
with duodenal ulcer have been statistically supported and as 
frequently contested. 
CHAPTER II 
METHODS AND MATERIALS 
A. Selection of Subjects 
Subjects for this investigation were selected from 
patients at Fantus Cleft Palate Clinic, Cook County Hospital 
and Loyola University, School of Dentistry. 
The test group studied included both males and 
females of the Caucasian, Negro, Oriental and Indian races, 
who exhibited a cleft lip/palate deformity. The clefts were 
present in any combination and to any degree of severity. 
A similar control group was used, comprised of subjects 
exhibiting no cleft lip/palate condition. 
Saliva samples were obtained and prepared in the 
following manner. 
1. The subject was asked to rinse the mouth with 
water before collection of the saliva. A clean 15 ml. size 
test tube was used to collect about 5 ml. of saliva. 
2. The specimen was transferred to another 15 ml. 
size test tube and heated in a boiling water bath for 10 to 
15 minutes to inactivate enzymes that destroy the blood 
group substances. 
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3. The specimen was centrifuged at 5,000 rpm for 
five minutes. 
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4. The clear supernatant was transferred to another 
clean 15 ml. size test tube. Because it was desirable to 
test all specimens at one time, the supernatant samples were 
frozen until testing could be performed. 
B. Method of Saliva Testing 
It has been found that an anti-H agglutinin, prepared 
by simple saline extraction of seeds of Ulex europeus, is 
suitable for the routine separation of individuals into 
secretors and non-secretors, merely by testing the ability 
of the subjects to inhibit the agglutination of group O 
erythrocytes by the undiluted Ulex extract. The procedure 
has the advantage of requiring only one reagent for saliva 
from individuals of any blood group, and only one type of 
erythrocytes for testing. 
The following inhibition test procedure was used to 
determine the secretor or non-secretor status of each of the 
test and control subjects. 
1. Into two properly marked 10 x 75 mm. tubes were 
added 1 drop of saliva (test) and 1 drop of 0.9% saline 
(control) respectively. 
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2. One drop of anti-H Lectin was added to each tube. 
3. The mixture was incubated at room temperature for 
ten minutes. 
4. One drop of a freshly three times washed 2% 
suspension of group O eel.ls in 0.9% NaCl solution was added 
to the test mixture. 
5. The mixture was incubated at room temperature for 
ten minutes. 
6. The tube was centrifuged at 3,400 rpm for 30 
seconds. 
7. The cells were gently resuspended and placed on 
a clean glass slide and read for the presence or absence 
of agglutination. 
Interpretation of the inhibition test for ABH secreter 
status is outlined below. 
Sec re tor 
The group o cells in the tube containing saliva 
are not agglutinated indicating that the anti-H has been 
neutralized by H substance in the saliva. 
Non-Secreter 
The group 0 cells in the tube containing saliva are 
agglutinated, indicating the absence of H substance in 
the saliva. 
11 
Control 
The group o cells in the control tube are agglutinated. 
CHAPTER III 
FINDINGS 
Table I contains the secretor/non-secretor reaction 
status for each member of the experimental and control 
sample. All subjects are listed according to their 
incidence of appearance by selection. 
Table II indicates the statistical evaluation of 
secretor/non-secretor frequency of occurrence measured by 
the Chi-square (X 2 ) Test. 
12 
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Table I 
Secretor/Non-Secretor Reaction Status of 
Experimental and Control Samples 
+ = secret or - = non-secreter 
Experimental Subjects Control Subjects (Cleft Lip/Palate Patients) 
1. D.B. + 1. K.J. 
2. B.W. + 2. J.S. + 
3. B.W. 3. J.P. + 
4. B.M. + 4. D.F. 
5. B.J. + 5. J.P. + 
6. D.L. + 6. D.P. + 
7. D.C. 7. E.B. + 
8. D.T. + 8. T.N. 
9. H.T. + 9. J.C. + 
10. R.M. + 10. J.L. + 
11. R.W. + 11. R.W. + 
12. L.H. 12. R.F. + 
13. R.T. + 13. J.D. + 
14. L.S. + 14. N.C. + 
15. M.G. + 15. K.S. 
16. c. I. + 16. D.S. + 
17. H.K. + 17. A.C. + 
18. A.A. + 18. B.S. 
19. L.G. + 19. P.H. + 
20. M.Z. 20. M.M. 
21. M.T. + 21. P.K. + 
22. E.H. 22. M.F. + 
23. G.B. + 23. N.B. + 
24. M.G. + 24. J.S. + 
25. D.E. + 25. G.T. 
26. E.W. + 26. J.S. + 
21 Secretors 19 Secretors 
5 Non-Secretors 7 Non-Secretors 
Table II 
Secretor/Non-Secretor Chi-Square (X 2 ) 
Evaluation of Significance 
The Chi-square formula is employed to determine 
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if any statistically significant frequency of occurrence 
of secretors/non-secretors exists. 
x 2 = ~ (Observed number - Expected number) 2 
Expected number 
x2 = £. (21 - 19) 2 
19 
x
2 
= o.782 
+ (5 - 7) 2 
7 
The value .782 represents a significance level of 
approximately 47%. A significance level of 5% and below 
is considered to be meaningful and merit further investigation. 
CHAPTER IV 
DISCUSSION 
The findings as revealed in Table I and Table II 
demonstrate that no significant difference of secreter/ 
non-secreter incidence exists between the cleft lip/palate 
patients and the control subjects in this experiment. 
While the primary purpose of this investigation was 
to determine if any significant relationship existed between 
cleft lip/palate and control incidence of secretor/non-
secretor ability, it seems appropriate to comment on the 
frequency of ABH secretors and non-secretors according to 
population. 
Frequency distinctions between secretors and non-
secretors are difficult to make. Before the utilization of 
Ulex the published figures for Europe varied with different 
workers. Further, North American Indians and Australian 
aborigines differ widely from the Europeans 7 in thirty 
Blood Indian families from Alberta all the parents were 
secretors, and in 120 aborigines all but four were secretors. 
Probably the best series of random people classified 
for ABH secretion is found in the controls of the Liverpool 
peptic ulcer investigations. Secretor tests on the saliva 
15 
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of 1,118 random "control" persons showed 77.28°/o secretors 
and 22.72% non-secretors. Other studies show that the 
ability to produce a water soluble substance of ABH speci-
ficity in the saliva is present in 75 to 80 percent of 
humans. 
Findings in this investigation disclose 73.0 percent 
secretors and 27.0 percent non-secretors in the control 
group. 80.7 percent secretors and 19.3 percent non-secretors 
were found in the cleft lip/palate test group. 
A. Summary 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
A research project was undertaken to investigate 
the possible existence of a relationship between the ABH 
saliva secreter status and cleft lip/palate subjects. A 
control group of similar subjects lacking the cleft lip/ 
palate abnormality was used. Both the test and control 
groups were composed of twenty-six subjects. The individuals 
tested were male and female of the Caucasian, Negro, Oriental 
and Indian races. 
The values of incidence were put to the mathematical 
Chi-square test to show the significance of correlation. 
The statistics obtained showed that when the test and control 
groups were compared to one another, they did not differ great-
ly and a significance level of approximately 47 percent 
existed as compared to the standard 5 percent level of 
significance. 
B. Conclusions 
The conclusions that can be stated from the findings 
in the experiment are the following. From this investigation 
it appears the incidence of cleft lip/palate anomalies have 
17 
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no significant relationship to the ABH secretor/non-secretor 
status of the saliva of the subject. Statistical testing 
by the Chi-square formula showed no significant value. The 
data obtained revealing the frequency of secretors and non-
secretors of the control and experimental subjects tended to 
agree with the frequency ranges of past research of control 
groups. 
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